Skip to main content
. 2021 Mar 2;13(5):1037. doi: 10.3390/cancers13051037

Figure 1.

Figure 1

Effects of type I interferons (IFNIs) on malignant cells and cells of the immune system. Exposure to type I IFNs alters the function of target cells within the tumor microenvironment (TME) in ways that promote anti-tumor effects (black) or counter such effects (red).